Aromidex – Exemestane 25mg
Aromidex is presented in the ORYVION catalog as a tablet formulation containing 25mg of exemestane per tablet, supplied in containers of 50 tablets. Exemestane is an orally active steroidal aromatase inhibitor that reduces estrogen production.
Its mechanism of action involves irreversible inactivation of aromatase, the enzyme responsible for converting androgens into estrogens. This reduces estrogen availability rather than directly blocking estrogen receptors. Its established medical applications include the treatment of certain hormone-sensitive breast cancers in postmenopausal women.
Product Specifications:
Commercial name: Aromidex
Listed compound: Exemestane
Declared strength: 25mg per tablet
Format: Tablets
Package contents: 50 tablets
Important Note:
Exemestane can reduce bone mineral density over time, increasing the risk of osteoporosis and fractures. Common adverse effects include hot flashes, joint pain, fatigue, and increased sweating. It can cause fetal harm and should not be used during pregnancy.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.